Experts advise on developments to look for in the transcatheter space when it comes to managing diseases of the mitral, tricuspid and pulmonary valves.
The investigational GATE tricuspid valved stent is the first transcatheter prosthesis to be placed directly at the tricuspid annulus in humans. Our specialists who performed the first case discuss the technology’s evolution.
A Cleveland Clinic team successfully completed the world’s first transcatheter tricuspid valve replacement in November 2016, raising hopes for a minimally invasive option for severe tricuspid regurgitation.
Surgeon Jose Navia, MD, explains the rationale and details of the incorporated aortomitral homograft technique he developed as an alternative to the “commando operation” for severe infective endocarditis.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Here’s the skinny on three new or emerging technologies that promise to make mitral valve procedures less invasive and/or more efficient.
The year just passed was full of insights and innovations likely to be felt for many years to come. Here are 15 such developments in which Cleveland Clinic staff played key roles.